false
Catalog
EP on EP Episode 65 - Atrial Fibrosis and Stroke R ...
EP on EP Episode 65_ Atrial Fibrosis and Stroke Ri ...
EP on EP Episode 65_ Atrial Fibrosis and Stroke Risk
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Nazem Akoum, Director of the AFib program at the University of Washington, discusses his research on atrial fibrosis and its role in predicting stroke risk. He criticizes the CHADS-VASc scoring system for its poor ability to predict strokes in AFib patients and proposes that atrial fibrosis may be a better indicator. His research shows that patients with AFib and a history of stroke have a higher fibrosis burden compared to those without stroke. Additionally, patients with embolic stroke of undetermined source (ESUS) have a higher incidence of recurrent stroke and newly diagnosed AFib if they have advanced atrial fibrosis. Further study is needed to determine the potential benefits of anticoagulation in these patients.
Keywords
atrial fibrosis
stroke risk
CHADS-VASc scoring system
AFib patients
fibrosis burden
Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy
|
Cookie Declaration
|
Linking Policy
|
Patient Education Disclaimer
|
State Nonprofit Disclosures
|
FAQ
×
Please select your language
1
English